NASDAQ | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ | TSX: ACB), the Canadian company that defines the future of cannabinoids around the world, has announced that it has completed the transfer of its stock exchange listing on the New York Stock Exchange (“NYSE”) Nasdaq Global Select Market (“Nasdaq”) after market close today.

The company’s common stock will begin trading as a Nasdaq-listed security when market opens on. May 25, 2021 and will continue to be listed under the ticker symbol “ACB”. This transition has no impact on the Company’s primary listing on the Toronto Stock Exchange (TSX: ACB). Aurora shareholders do NOT need to take any further action.

The move to the Nasdaq listing is part of Aurora’s recently announced profitability initiatives and aligns the company with other cannabis peers on an exchange known for its innovative and growth-oriented businesses.

The last day of trading of the company’s common shares on NYSE was May 24, 2021 .

About Aurora

Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Based at Edmonton, Alberta , Aurora is a global cannabis pioneer dedicated to helping people improve their lives. The company’s brand portfolio includes Aurora, Aurora Drift, San Rafael ’71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler and Reliva CBD. Providing customers with innovative and high-quality cannabis products, Aurora’s brands continue to establish themselves as industry leaders in the medicine, performance, wellness and wellness markets. and recreation, wherever they are launched. For more information, please visit our website at www.auroramj.com .

Aurora’s common shares trade on the TSX and NASDAQ under the symbol “ACB” and are included in the S & P / TSX Composite Index.

Forward-looking statements

This press release contains statements containing certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”). Forward-looking statements are often characterized by words such as “plan”, “continue”, “expect”, “plan”, “intend”, “believe”, “anticipate”, “estimate”, “may “,” Will “,” Potential “,” proposed “and other similar words, or statements that certain events or conditions” may “or” will occur “. These forward-looking statements are only predictions. Various assumptions have been used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this press release. Forward-looking statements are based on the opinions, estimates and assumptions of management in light of management’s experience and perception of historical trends, current conditions and expected developments at the date the statements are made. made, such as current and future market conditions, the ability to maintain General and administrative expenses are in line with current expectations, the ability to achieve high margin revenues in the Canadian consumer market, the current and future regulatory environment and future approvals and permits. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management considers relevant and reasonable in the circumstances could cause events, results, level of activity, performance, actual prospects, opportunities or achievements differ materially from these. projected in the forward-looking statements, including the risks associated with: entering the US market, the ability to realize the expected benefits associated with the acquisition of Reliva, the completion of Aurora’s business transformation plan, the conditions business and economic conditions, changes in laws and regulations, demand for products, changes in the prices of required commodities, competition, effects and responses to the COVID-19 pandemic and other risks, uncertainties and factors defined under the heading “Factors of risk ”of the Company’s Annual Information Form dated September 24, 2020 (the “Annual Information Form”) and filed with the Canadian Securities Administrators available on the Company’s Issuer Profile on SEDAR at www.sedar.com and filed with and available on the SEC’s website at www.edgar.gov . The Company cautions that the list of risks, uncertainties and other factors described in the Annual Information Form is not exhaustive and that other factors could also adversely affect its results. Readers are urged to carefully consider risks, uncertainties and assumptions when evaluating forward-looking statements, and are cautioned not to place undue reliance on such information. The Company has no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as expressly required. by applicable securities laws.

Show original content to download multimedia: http://www.prnewswire.com/news-releases/aurora-cannabis-to-begin-trading-on-the-the-nasdaq-global-select-market-on-may-25-2021-at-market- open-301297980.html

SOURCE Aurora Cannabis Inc.